Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Physics and Imaging in Radiation Oncology|August 14, 2024
Robustness of radiomics features on 0.35 T magnetic resonance imaging for magnetic resonance-guided radiotherapyMorgan Michalet, Gladis Valenzuela, Pierre Debuire, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|July 17, 2023
Implementation of the Calypso system: a commissioning experienceJessica Prunaretty, Pierre Debuire, Duncan Cirella, et al.
Physics in Medicine and Biology|December 29, 2022
Characterisation of a split gradient coil design induced systemic imaging artefact on 0.35 T MR-linac systemsLouis Marage, Paul-Michael Walker, Julien Boudet, et al.
Advances in Radiation Oncology|October 14, 2021
Magnetic Resonance-Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry StudyMorgan Michalet, Olivier Riou, Simon Valdenaire, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 9, 2025
Image-guided intensity-modulated radiotherapy with reduced margins in patients with prostate cancer: Results of the RCMIGI randomized phase II trialOlivier Riou, Pascal Fenoglietto, Marta Jarlier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 15, 2025
Magnetic resonance guided stereotactic reirradiation for locally recurrent prostate cancers: Long-term results from a prospective registry studyChloé Buchalet, Olivier Riou, Rémi Colin, et al.
Cancers|April 23, 2022
Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry StudyMorgan Michalet, Olivier Riou, Jeremy Cottet-Moine, et al.
Frontiers in Oncology|March 31, 2022
Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry StudyMorgan Michalet, Karl Bordeau, Marie Cantaloube, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2023
A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumorsKarl Bordeau, Morgan Michalet, Valérie Dorion, et al.
Cancers|January 8, 2023
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry StudyKarl Bordeau, Morgan Michalet, Aïcha Keskes, et al.
Pageof 2